New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future (Q37996998)

26 August 2017

title

New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future (English)

1 reference

26 August 2017

0 references

1 reference

26 August 2017

Mario Raviglione

0 references

Michael Hoelscher

1 reference

26 August 2017

Richard Hafner

1 reference

26 August 2017

Ernesto Jaramillo

1 reference

26 August 2017

Christian Lienhardt

1 reference

26 August 2017

Mel Spigelman

1 reference

26 August 2017

Jan Gheuens

series ordinal

1 reference

26 August 2017

language of work or name

English

0 references

publication date

22 March 2012

1 reference

Journal of Infectious Diseases

26 August 2017

published in

1 reference

26 August 2017

volume

205 Suppl 2

1 reference

26 August 2017

page(s)

S241-9

1 reference

Global tuberculosis drug development pipeline: the need and the reality.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Design issues in pivotal drug trials for drug sensitive tuberculosis (TB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Three months of rifapentine and isoniazid for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Chemotherapy of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Whither short-course chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Challenges in tuberculosis drug research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Integration of antiretroviral therapy with tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Tuberculosis drug development: ensuring people living with HIV are not left behind

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Timing of initiation of antiretroviral drugs during tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Viewpoint: Challenges and opportunities in tuberculosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS034

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS034

1 reference

26 August 2017

1 reference